Contamination from ethylene glycol and diethylene glycol in liquid formulation poses a high risk to patient safety. Throughout recent years there have been multiple fatalities reported due to the presence of these contaminants in drug products. This whitepaper covers the testing of high-risk drug components for ethylene glycol and diethylene glycol.
This whitepaper is ideal for
- Pharmaceutical manufacturers
- Compounders
- CDMOs
- CROs
For a full discussion of the content in this whitepaper, you can also watch the on-demand webinar.
